Atlas Trials

A Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of KR23248 Capsules in Healthy Adult Subjects

Clinical trial NCT07585383 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07585383
Sponsor
Jiangxi Kvvit Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2026-05-19
Primary completion
2026-11-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.